|
|
||||||||
1 Graduate Program in Molecular Biophysics, Florida State University, Tallahassee, Florida 32306, USA
2 Department of Chemistry, Florida State University, Tallahassee, Florida 32306, USA
3 The National High Magnetic Field Laboratory, Tallahassee, Florida 32310, USA
Reprint requests to: Timothy M. Logan, The Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA; email: logan{at}sb.fsu.edu; fax: (850) 561-1406.
(RECEIVED April 16, 2001; FINAL REVISION May 22, 2001; ACCEPTED May 23, 2001)
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1101/
| Abstract |
|---|
|
|
|---|
-helix of FKBP. These structural perturbations probably account for the differential stability. In contrast to the relatively minor equilibrium effects, the N-terminal extension generated a kinetic-folding intermediate that is not observed in the shorter construct. Kinetic experiments performed on a construct with a different amino acid sequence in the extension showed that the length and the sequence of the extension both contribute to the observed equilibrium and kinetic effects. These results point to an important role for the N terminus in the folding of FKBP and suggest that a biological consequence of N-terminal methionine removal observed in many eukaryotic and prokaryotic proteins is to increase the folding efficiency of the polypeptide chain. Keywords: Protein folding; kinetic intermediate; expression system; N terminus; stopped-flow
| Introduction |
|---|
|
|
|---|
-helix, and three loops. There are no disulfides and all seven proline residues are in the trans conformation in the native state. The structure of the protein has been determined to high resolution in several forms by X-ray crystallography and NMR (Michnik et al. 1991; van Duyne et al. 1991, 1993; Meadows et al. 1993). FKBP catalyzes peptidyl-prolyl cis-trans isomerization and there is significant interest in the stability and folding of FKBP due to the possibility of autocatalyzed folding (Egan et al. 1993; Scholz et al. 1996; Veeraraghavan et al. 1996; Main et al. 1998, 1999; Fulton et al. 1999). We are using FKBP as a model system to investigate how nonrandom structure present in the urea-unfolded state affects subsequent folding events. Specifically, we are using an FKBP variant in which the single Cys at position 22 has been replaced by Ala (C22A). This mutation has little effect on the thermodynamic stability, structure, or chemical mechanism of FKBP (Park et al. 1992), but allows us to perform reversible differential scanning calorimetry experiments with minimal loss of protein (data not shown). To facilitate the purification of mutant proteins, we have generated a fusion construct between a modified form of the pMALc2 plasmid vector and the FKBP C22A structural gene. The modification adds eight histidine residues (H8) in a 17-residue linker after the maltose-binding protein (MBP) gene and immediately preceding a thrombin proteolytic site (Pryor and Leitung 1997), which replaces the less efficient Factor Xa cleavage site. Removal of the MBP-H8 affinity tag with thrombin leaves three additional amino acid residues on the N terminus of the C22A gene.
Many of the current plasmids used for expressing recombinant proteins in Escherichia coli result in N-terminal extensions of one or more amino acids because of the particular restriction endonuclease sites used for cloning and from proteolytically cleavable or noncleavable affinity tags used to aid purification. These tags are generally innocuous to the recombinant protein, and may even provide additional stability and solubility (Davis et al. 1999). Here, we report isothermal equilibrium denaturation and kinetic-folding studies of two extended FKBP constructs. These data show that N-terminal extension has a small, but significant impact on the thermodynamic stability. This result may be anticipated from the three dimensional structure of FKBP. However, the extension has an unexpected and substantial effect on the folding kinetics and apparent folding pathway of this small, single-domain protein. We show that this effect has contributions both from the size and amino acid sequence of the N-terminal extension.
| Results and Discussion |
|---|
|
|
|---|
G°unf, is zero, and of the equilibrium m-value, which is related to the free energy of transfer of the protein between two solvents and is interpreted structurally as being proportional to the change in nonpolar surface area of the protein exposed to the solvent upon (un)folding (Schellman 1987a,b, 1994). As shown in Table1
|
|
G°unf of 4.87 kcal/mole, which is slightly lower than values published previously for true wild-type FKBP (Egan et al. 1993; Main et al. 1998). In contrast, the D50 for gsmFKBP and gsgFKBP were reduced to 2.69 M and 2.48 M urea, yielding
G°unf values of 4.38 and 3.12 kcal/mole at 30°C, respectively. In fact, the gsgFKBP construct was so destabilized that the purification and cleavage procedure had to be modified to increase the yield following thrombin digestion. Interestingly, the Schmid group also observed a destabilization (D50 = 2.9 M urea) coupled with an increased tendency for precipitation when FKBP was expressed with a sixteen residue N-terminal extension containing a histidine tag (Scholz et al. 1996).
A structural basis for the decreased stability in gsmFKBP was apparent from a comparison of 2D 1H,15N correlation experiments (Kay et al. 1992). Figure 2A
shows the differences in chemical shifts of the backbone amide 1H and 15N resonances between the C22A and gsmFKBP constructs, and Figure 2B
shows the location of the perturbed residues in the native structure of FKBP. The largest differences in chemical shift are observed for residues V2, K35, S77, D79, Y82, and G83. Except for V2, these residues are located in the single-turn 310 helix and at the base of the
-shaped loop connecting ß-strands II and III of native FKBP (red balls, Fig. 2B
). Smaller chemical shift differences are observed for residues Q3, V4, I56, R57, W59-G62, and A95. Residues I56G62 are in the single
-helix, which is located above the plane of the five-stranded ß-sheet, whereas Q3, V4, and A95 are in ßI and ßII, adjacent to the N terminus. The NMR results suggested that steric contacts between the gsm extension and residues adjacent to the N terminus were the likely cause for the decreased equilibrium stability of gsmFKBP relative to C22A. Because the gsgFKBP construct is further destabilized relative to gsmFKBP and C22A, the steric interactions are not likely to arise solely from the methionine side chain.
|
40% slower than C22A (2.85 s-1 vs. 4.46 s-1, respectively), whereas the unfolding rate, k°u, is more than three times faster (0.054 s-1 vs. 0.014 s-1, respectively). The gsgFKBP variant folds with a rate similar to gsmFKBP (2.73 s-1), but unfolds more slowly than C22A FKBP (0.007 s-1). The ratio of the unfolding and folding rates does not equal the equilibrium constant for denaturation obtained from
G°unf in each protein construct due, at least in part, to the fact that the kinetic values reported here do not account for subsequent kinetic phases occurring on significantly longer time frames that are due to prolyl isomerization (Veeraraghavan et al. 1996; Main et al. 1999).
|
The folding pathway of FKBP is not documented as thoroughly as that of other proteins. Therefore, in contrast to the thermodynamic results, a structural explanation for the observed kinetic changes is not immediately apparent, and mechanisms proposed for intermediate formation must be regarded as speculative at this stage. One potential source of folding intermediates in FKBP is the loop crossing (Michnik et al. 1991). Loop crossings are not commonly observed in antiparallel ß-sheet proteins, but are thought to slow folding and possibly generate kinetic folding intermediates when present (Richardson 1977; Ptitsyn and Finkelstein 1980). However, the loop crossing seems an unlikely source for the folding intermediates observed here because wild-type FKBP and C22A, which contain this loop crossing, do not exhibit kinetic folding intermediates on this time scale.
The observed folding intermediate must reflect a change in how the N terminus packs into the rest of the protein in the extended variants.
-value analysis and molecular dynamics simulations indicate that the ß-sheet structure in FKBP is loosely formed in the folding transition state, in particular with respect to ßI (Fulton et al. 1999). Mutations to residue I7, which is at the C-terminal end of ßI and near the loop crossing, have a low
-value (0.1) compared with mutations to V2, which is at the N-terminal end of ßI (
-value of 0.5) (Fulton et al. 1999). Fractional
-values are difficult to interpret structurally, but it is possible that the N-terminal part of ß1 is more native like at the transition state than residues at the C-terminal end of ß1. In other words, the N-terminal end of ß1, at the free end of the polypeptide chain, may form the initial contacts that lead to ß-strand formation, rather than strand formation starting from the C-terminal end of ß1. Perhaps the three additional residues at the N terminus of FKBP alter interaction of ßI with residues in the single-turn helix during folding. These interactions may force this ß-strand to pack into the rest of the protein via a different route, resulting in the formation of a kinetic-folding intermediate.
Our results point to an important role for the N terminus in the folding of FKBP, which exhibits considerable sequence variability among FKBP homologs. Homologs such as the E. coli SlyD (Hottenrott et al. 1997) and the MbFK from Methanobacterium thermoautotrophicum (Ideno et al. 2000), lack the N-terminal ß-strand, ß1 (using the nomenclature for the FKBP12). In these proteins, the N terminus begins in the loop connecting ß1 and ß4 in FKBP12, which presumably eliminates the loop crossing found in longer FKBPs. On the other hand, the FKBP domain from hsp56 (FKBP59) contains an additional 30 residues preceding the N terminus of FKBP12 (Craescu et al. 1996). These residues form a small loop and a short ß-strand that pairs with the strand that is structurally homologous to ß1 in FKBP12. Investigating the folding and unfolding reactions of these variants may provide additional insights into the role of the N terminus in FKBP folding.
In conclusion, a three-residue extension on the N terminus of FKBP slightly alters the thermodynamic stability, but more dramatically, alters the kinetic-folding pathway of the protein. Both the extension and its the amino acid sequence contribute to this effect. Like many proteins, the N-terminal Met residue is not present in mature FKBP12 isolated from eukaryotic sources (Harding et al. 1988), and is also removed when expressed recombinantly in prokaryotes (Standaert et al. 1990). In other words, translation of the FKBP cDNA results in a protein that is apparently too long by one residue at the N terminus. Methionine residues are frequently removed proteolytically from polypeptide chains either co- or post-translationally (Bradshaw et al. 1998), and it is interesting to speculate about why the N-terminal Met residue of FKBP is removed. The N-terminal residue is linked to the proteins in vivo half-life, as developed in the N-end rule (Varshavsky 1996). Gly, the first residue in mature FKBP, is a stabilizing residue against proteolytic degradation via the ubiquitin pathway, as is Met, so this cannot explain the Met removal in FKBP. Instead, our data suggests that the N-terminal Met residue in FKBP, and perhaps that of other proteins, is removed to stabilize the protein against denaturation and to improve the folding efficiency by removing a kinetic intermediate on the folding pathway.
| Materials and methods |
|---|
|
|
|---|
Isothermal equilibrium denaturation
Purified protein was concentrated and exchanged into 50 mM sodium phosphate buffer containing 25 mM NaCl (pH 6.4) for storage. Samples for isothermal equilibrium denaturation were generated by adding the appropriate amount of protein to solutions containing the desired final urea concentration, and allowed to come to equilibrium at 30°C prior to monitoring the extent of unfolding by fluorescence. Urea concentrations were determined by measuring the refractive index of the solution (Pace 1986). Isothermal equilibrium denaturation was monitored by the change in the intrinsic fluorescence of W59 (emission spectra) following established protocols (Egan et al. 1993). Fluorescence intensity was integrated from 310500 nm and normalized to protein concentration. The data were fit to a model that assumes a two-state transition (Equation 1
) by use of a Marquardt-Levenson algorithm implemented in Kaleidagraph.
![]() | (1) |
In this equation, derived from the linear extrapolation model (Santoro and Bolen 1988),
N (
U) and ßN (ßU) are the intercepts and slopes of the pre-(post)-transition baselines, respectively, D is the denaturant concentration, m is the molar cosolvation free energy, and D50 is the denaturant concentration at which the protein is 50% in the native state. The free energy of unfolding in the absence of denaturant,
G°unf, was determined by
![]() | (2) |
Stopped-flow kinetic folding and unfolding
Stopped-flow experiments were performed by use of a Kintec SF-100 at 30°C. Folding and unfolding reactions were followed by fluorescence emission selected by use of a 340-nm interference filter after excitation at 280 nm. Unfolding or folding were initiated by diluting protein solution into unfolding or folding buffer starting from native or unfolded protein, respectively. The kinetic traces, averaged from 1315 single shots, were fitted to a single exponential term for the time frame between 50 ms and 1 sec. The rate for each individual concentration below 2.0 M and above 3.0 M urea was fitted to a kinetic scheme that assumes a two-state reaction in which the dependence of the unfolding and refolding rates are assumed to have a linear dependence on urea concentration,
![]() | (3) |
In Equation 3
, k°f and k°u represent the folding and unfolding rates in the absence of denaturant. The folding (mf) and unfolding (mu) kinetic m-values, which are analogous to the equilibrium m-values, report on structural changes as the protein approaches the transition state from the native and unfolded states, respectively.
| Acknowledgments |
|---|
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| References |
|---|
|
|
|---|
-acetyl transferase families. Trends Biochem. Sci. 23: 263276.[CrossRef][Medline]Craescu, C.T., Rouviére, N., Popescu, A., Cerpolinin, E., Lebeau, M.-C., Baulieu, E.-E., and Mispelter, J. 1996. Three dimensional structure of the immunophilin-like domain of FKBP59 in solution. Biochemistry 35: 1104511052.[CrossRef][Medline]
Davis, G.D., Elisee, C., Newham, D.M., and Harrison, R.G. 1999. New fusion protein systems designed to give soluble expression in Eschericia coli. Biotechnol. Bioengin. 65: 382388.[CrossRef][Medline]
Egan, D.A., Logan, T.M., Liang, H., Matayoshi, E., Fesik, S.W., and Holzman, T.F. 1993. Equilibrium denaturation of recombinant human FK binding protein in urea. Biochemistry 32: 19201927.[CrossRef][Medline]
Fulton, K.F., Main, E.R.G., Daggett, V., and Jackson, S.E. 1999. Mapping the interactions present in the transition state for unfolding/folding of FKBP12. J. Mol. Biol. 291: 445461.[CrossRef][Medline]
Harding, M.W., Galai, A., Uehling, D.E., and Schreiber, S.L. 1988. A receptor for the immuno-supressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341: 758760.
Hottenrott, S., Schumann, T., Plückthun, A., Fischer, G., and Rahfield, J.U. 1997. The Eschericia coli SlyD is a metal ion-regulated peptidyl-prolyl cis/trans isomerase. J. Biol. Chem. 272: 15697 15701.
Ideno, A., Yoshida, T., Furutani, M., and Maruyama, T. 2000. The 28.3 kDa FK506 binding protein from a thermophilic archaeum, Methanobacterium thermautotrophicum, protects the denaturation of proteins in vitro. Eur. J. Biochem. 267: 31393148.[Medline]
Kay, L.E., Keifer, P., and Saarinen, T. 1992. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114: 1066310665.[CrossRef]
Koradi, R., Billeter, M., and Wüthrich, K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graphics 14: 5155.[CrossRef][Medline]
Main, E.R.G., Fulton, K.F., and Jackson, S.E. 1998. Context-dependent nature of destabilizing mutations on the stability of FKBP12. Biochemistry 37: 61456153.[CrossRef][Medline]
. 1999. Folding pathway of FKBP12 and characterisation of the transition state. J. Mol. Biol. 291: 429444.[CrossRef][Medline]
Meadows, R.P., Nettesheim, D.G., Xu, R.X., Olejniczak, E.T., Petros, A.M., Holzman, T.F., Severin, J., Gubbins, E., Smith, H., and Fesik, S.W. 1993. Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. Biochemistry 32: 754 765.[CrossRef][Medline]
Michnik, S., Rosen, M.K., Wandless, T.J., Karplus, M., and Schreiber, S. 1991. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. Science 252: 836.
Otzen, D.E., Kristensen, O., Proctor, M., and Oliveberg, M. 1999. Structural changes in the transition state of protein folding: Alternative interpretations of curved chevron plots. Biochemistry 38: 64996511.[CrossRef][Medline]
Pace, C.N. 1986. Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods. Enzymol. 131: 266280.[Medline]
Park, S.T., Aldape, R.A., Futer, O., DeCenzo, M.T., and Livingston, D.J. 1992. PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism. J. Biol. Chem. 267: 33163324.
Parker, M.J., Spencer, J., and Clarke, A.R. 1995. An integrated kinetic analysis of intermediates and transition states in protein folding rections. J. Mol. Biol. 253: 771786.[CrossRef][Medline]
Pilot-Mathias, T., Pratt, S.D., and Lane, B.C. 1993. High-level synthesis of the 12-kDa human FK506-binding protein in Eschericia coli using translational coupling. Gene 128: 219225.[CrossRef][Medline]
Pryor, K.D. and Leitung, B. 1997. High-level expression of soluble protein in Eschericia coli using a His6-tag and maltose binding protein double affinity fusion system. Protein Exp. Purific. 10: 309319.[CrossRef][Medline]
Ptitsyn, O.B. and Finkelstein, A.V. 1980. Similarities of protein topologies: Evolutionary divergence, functional convergence, or principles of folding? Q. Rev. Biophys. 13: 339386.[Medline]
Raschke, T.M. and Marqusee, S. 1997. The kinetic folding intermediate of ribonuclease H resembles the acid molten globule and partially unfolded molecules detected under native conditions. Nature Struct. Biol. 4: 298304.[CrossRef][Medline]
Richardson, J.S. 1977. ß-Sheet topology and the relatedness of proteins. Nature 268: 495500.[CrossRef][Medline]
Santoro, M.W. and Bolen, D.W. 1988. Unfolding free energy changes determined by the linear extrapoloation method. I. Unfolding of phenylmethanesulfonyl
-chymotrypsin using different denaturants. Biochemistry 27: 80638068.[CrossRef][Medline]
Schellman, J.A. 1987a. Selective binding and solvent denaturation. Biopolymers 26: 549559.[CrossRef][Medline]
. 1987b. The thermodynamic stability of proteins. Annu. Rev. Biophys. Chem. 16: 115137.[CrossRef][Medline]
. 1994. The thermodynamics of solvent exchange. Biopolymers 34: 10151026.[CrossRef][Medline]
Scholz, C., Zarnt, T., Kern, G., Lang, K., Burtscher, H., Fischer, G., and Schmid, F.X. 1996. Autocatalytic folding of the folding catalyst FKBP12. J. Biol. Chem. 271: 1270312707.
Standaert, R.F., Galat, A., Verdine, G., and Schreiber, S.L. 1990. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature 346: 671674.[CrossRef][Medline]
van Duyne, G.D., Standaert, R.F., Karplus, P.A., Schreiber, S.L., and Clardy, J. 1991. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science 252: 839842.
. 1993. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229: 105124.[CrossRef][Medline]
Varshavsky, A. 1996. The N-end rule: Functions, mysteries, uses. Proc. Natl. Acad. Sci. 93: 1214212149.
Veeraraghavan, S., Holzman, T.F., and Nall, B.T. 1996. Autocatalyzed protein folding. Biochemistry 35: 1060110607.[CrossRef][Medline]
Wilson, K., Yamashita, M.M., Sintchak, M.D., Rotstein, S.H., Murcko, M.A., Boger, J., Thompson, J.A., Fitzgibbon, M.J., and Navia, M.A. 1995. Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unligated for and in complex with FK506 and rapamycin. Acta Cryst. D. 51: 511517.
Zhang, Z., Li, W., Logan, T.M., Li, M., and Marshall, A.G. 1997. Human recombinant [C22A] FK506 binding protein amide hydrogen exchange rates from mass spectrometry match and extend those from NMR. Protein Sci. 6: 22032217.[Abstract]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. A. Maynard-Smith, L.-c. Chen, L. A. Banaszynski, A. G. L. Ooi, and T. J. Wandless A Directed Approach for Engineering Conditional Protein Stability Using Biologically Silent Small Molecules J. Biol. Chem., August 24, 2007; 282(34): 24866 - 24872. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Japrung, S. Chusacultanachai, J. Yuvaniyama, P. Wilairat, and Y. Yuthavong A simple dual selection for functionally active mutants of Plasmodium falciparum dihydrofolate reductase with improved solubility Protein Eng. Des. Sel., October 1, 2005; 18(10): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Korepanova, F. P. Gao, Y. Hua, H. Qin, R. K. Nakamoto, and T. A. Cross Cloning and expression of multiple integral membrane proteins from Mycobacterium tuberculosis in Escherichia coli Protein Sci., January 1, 2005; 14(1): 148 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Doyle, E. Anderson, K. N. Parent, and C. M. Teschke A Concerted Mechanism for the Suppression of a Folding Defect through Interactions with Chaperones J. Biol. Chem., April 23, 2004; 279(17): 17473 - 17482. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |